Update of efficacy results from XELOX-1/NO16966, a randomised phase III trial of XELOX vs. FOLFOX4 as first-line treatment for patients with metastatic colorectal cancer (MCRC) Meeting Abstract


Authors: Cassidy, J.; Clarke, S.; Díaz-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; Koski, S.; Sirzén, F.; Gilberg, F.; Saltz, L.
Abstract Title: Update of efficacy results from XELOX-1/NO16966, a randomised phase III trial of XELOX vs. FOLFOX4 as first-line treatment for patients with metastatic colorectal cancer (MCRC)
Meeting Title: 10th World Congress on Gastrointestinal Cancer
Journal Title: Annals of Oncology
Volume: 19
Issue: Suppl. 6
Meeting Dates: 2008 Jun 25-28
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2008-06-01
Start Page: vi27
Language: English
ACCESSION: WOS:000257951800064
PROVIDER: wos
DOI: 10.1093/annonc/mdn360
PUBMED: 18584779
Notes: Meeting Abstract - Poster Discussion No.: PD-026 - 10th World Congress on Gastrointestinal Cancer - JUN 25-28, 2008 - Barcelona, SPAIN - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    790 Saltz